Early-stage biotech ventures face high R&D costs, long development timelines, regulatory hurdles, scientific risks, funding challenges, talent acquisition issues, IP concerns, market acceptance difficulties, partnership needs, manufacturing and scalability problems, and ethical considerations. Overcoming these requires strategic planning, strong leadership, robust funding, and clear commercialization pathways.